Abstract
Background: Cannabis sativa-derived substances such as cannabidiol (CBD) have attracted increasing clinical interest and consist in a new perspective for treating some neurological and psychiatric diseases.
Aims: The aim of this work was to investigate the effect of acute treatment with CBD on panic-like defensive responses displayed by mice threatened by the venomous snake Bothrops jararaca.
Methods: Mice were habituated in the enriched polygonal arena for snake panic test. After recording the baseline responses of the tail-flick test, the prey were pretreated with intraperitoneal (i.p.) administrations of the endocannabinoid type 1 receptor (CB1) antagonist AM251 (selective cannabinoid 1 receptor antagonist with an IC50 of 8 nM) at different doses, which were followed after 10 min by i.p. treatment with CBD (3 mg/kg). Thirty minutes after treatment with CBD, mice were subjected to confrontations by B. jararaca for 5 min, and the following defensive responses were recorded: risk assessment, oriented escape behaviour, inhibitory avoidance and prey-versus-snake interactions. Immediately after the escape behaviour was exhibited, the tail-flick latencies were recorded every 5 min for 30 min.
Outcomes: Mice threatened by snakes displayed several anti-predatory defensive and innate fear-induced antinociception responses in comparison to the control. CBD significantly decreased the risk assessment and escape responses, with a consequent decrease in defensive antinociception. The CBD panicolytic effect was reversed by i.p. treatment with AM251.
Conclusions: These findings suggest that the anti-aversive effect of CBD depends at least in part on the recruitment of CB1 receptors.
Keywords: Bothrops jararaca, Cannabidiol, TRPV1 channel, cannabinoid type 1 receptor, defensive behaviour, prey versus snake confrontation, unconditioned fear-induced antinociception
Similar articles
-
Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus.Psychopharmacology (Berl). 2020 Apr;237(4):1063-1079. doi: 10.1007/s00213-019-05435-5. Epub 2020 Jan 9.PMID: 31919563
-
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-cannabinoid receptor in the ventral mesencephalon.Eur J Pharmacol. 2015 Jul 5;758:153-63. doi: 10.1016/j.ejphar.2015.03.051. Epub 2015 Apr 2.PMID: 25841876
-
Opioid neurotransmission modulates defensive behavior and fear-induced antinociception in dangerous environments.Neuroscience. 2017 Jun 23;354:178-195. doi: 10.1016/j.neuroscience.2017.04.032. Epub 2017 Apr 27.PMID: 28457818
-
Critical neuropsychobiological analysis of panic attack- and anticipatory anxiety-like behaviors in rodents confronted with snakes in polygonal arenas and complex labyrinths: a comparison to the elevated plus- and T-maze behavioral tests.Braz J Psychiatry. 2017 Jan-Mar;39(1):72-83. doi: 10.1590/1516-4446-2015-1895. Epub 2017 Feb 6.PMID: 28177062 Free PMC article. Review.
-
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3364-78. doi: 10.1098/rstb.2011.0389.PMID: 23108553 Free PMC article. Review.